is compound tirzepatide banned ban update π’Important FDA Update on Compounded Tirzepatide! Due to recent FDA regulations FDA Ban on Compounded GLP-1
Description
The sites confirmed as appropriate for GLP-1 class drugs (abdomen, thigh, upper arm) apply to retatrutide's subcutaneous route regardless of whether delivery is via pen or syringe

In TRIUMPH-4, participants taking retatrutide achieved substantial weight loss and reported improvements in pain and physical function compared to placebo

Research shows most people exceed this threshold within the first three months

Epub ahead of print 21 December 2021

Consequently, a more conservative stepwise dose escalation would be required when initiating IcoSema treatment compared with semaglutide treatment alone
Excellent early review of the physiology of lymphocyte adhesion to inflamed endothelium
